MetLife, Inc. (MET)
Sells life insurance, health coverage, and retirement savings products to individuals and employers worldwide.
$95.19+0.00%Financial Services
StockGlow Score
Bullish
BearishBullish
1 year ago+28.6%
The outlook
MetLife is trading near the top of its 52-week range, well above both its 50- and 200-day moving averages, signaling an uptrend in play. Analyst consensus leans bullish with a "Buy" rating, and the average price target sits roughly 3% above the current level. The stock trades at a trailing P/E of 18.4 against a backdrop of broad analyst support.
What’s behind the score
Analyst consensusBuy — 1.9 avg of 16 analysts
Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Price targetAvg target +3% vs current price
Analyst price target
~12-month · 16 analysts$97.75average target+2.7% vs now
Now $95.19
Low $75.00High $106.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$61.25B
52-wk high
$96.00
52-wk low
$67.33
50-day avg
$87.15
200-day avg
$79.41
Trailing P/E
18.4